117 related articles for article (PubMed ID: 29796658)
1. BCL2 Regulates Differentiation of Intestinal Fibroblasts.
Weder B; Mamie C; Rogler G; Clarke S; McRae B; Ruiz PA; Hausmann M
Inflamm Bowel Dis; 2018 Aug; 24(9):1953-1966. PubMed ID: 29796658
[TBL] [Abstract][Full Text] [Related]
2. Novel PPARγ Modulator GED-0507-34 Levo Ameliorates Inflammation-driven Intestinal Fibrosis.
Speca S; Rousseaux C; Dubuquoy C; Rieder F; Vetuschi A; Sferra R; Giusti I; Bertin B; Dubuquoy L; Gaudio E; Desreumaux P; Latella G
Inflamm Bowel Dis; 2016 Feb; 22(2):279-92. PubMed ID: 26535766
[TBL] [Abstract][Full Text] [Related]
3. Severity of local inflammation does not impact development of fibrosis in mouse models of intestinal fibrosis.
Hünerwadel A; Fagagnini S; Rogler G; Lutz C; Jaeger SU; Mamie C; Weder B; Ruiz PA; Hausmann M
Sci Rep; 2018 Oct; 8(1):15182. PubMed ID: 30315190
[TBL] [Abstract][Full Text] [Related]
4. Targeting of BCL2 Family Proteins with ABT-199 and Homoharringtonine Reveals BCL2- and MCL1-Dependent Subgroups of Diffuse Large B-Cell Lymphoma.
Klanova M; Andera L; Brazina J; Svadlenka J; Benesova S; Soukup J; Prukova D; Vejmelkova D; Jaksa R; Helman K; Vockova P; Lateckova L; Molinsky J; Maswabi BC; Alam M; Kodet R; Pytlik R; Trneny M; Klener P
Clin Cancer Res; 2016 Mar; 22(5):1138-49. PubMed ID: 26467384
[TBL] [Abstract][Full Text] [Related]
5. Bcl2L12 with a BH3-like domain in regulating apoptosis and TMZ-induced autophagy: a prospective combination of ABT-737 and TMZ for treating glioma.
Yang MC; Loh JK; Li YY; Huang WS; Chou CH; Cheng JT; Wang YT; Lieu AS; Howng SL; Hong YR; Chou AK
Int J Oncol; 2015 Mar; 46(3):1304-16. PubMed ID: 25586056
[TBL] [Abstract][Full Text] [Related]
6. BAX and BAK1 are dispensable for ABT-737-induced dissociation of the BCL2-BECN1 complex and autophagy.
Pedro JM; Wei Y; Sica V; Maiuri MC; Zou Z; Kroemer G; Levine B
Autophagy; 2015; 11(3):452-9. PubMed ID: 25715028
[TBL] [Abstract][Full Text] [Related]
7. HSP90 inhibitor (NVP-AUY922) enhances the anti-cancer effect of BCL-2 inhibitor (ABT-737) in small cell lung cancer expressing BCL-2.
Yang H; Lee MH; Park I; Jeon H; Choi J; Seo S; Kim SW; Koh GY; Park KS; Lee DH
Cancer Lett; 2017 Dec; 411():19-26. PubMed ID: 28987383
[TBL] [Abstract][Full Text] [Related]
8. Inhibiting Interleukin 36 Receptor Signaling Reduces Fibrosis in Mice With Chronic Intestinal Inflammation.
Scheibe K; Kersten C; Schmied A; Vieth M; Primbs T; Carlé B; Knieling F; Claussen J; Klimowicz AC; Zheng J; Baum P; Meyer S; Schürmann S; Friedrich O; Waldner MJ; Rath T; Wirtz S; Kollias G; Ekici AB; Atreya R; Raymond EL; Mbow ML; Neurath MF; Neufert C
Gastroenterology; 2019 Mar; 156(4):1082-1097.e11. PubMed ID: 30452921
[TBL] [Abstract][Full Text] [Related]
9. Analysis of intestinal fibrosis in chronic colitis in mice induced by dextran sulfate sodium.
Suzuki K; Sun X; Nagata M; Kawase T; Yamaguchi H; Sukumaran V; Kawauchi Y; Kawachi H; Nishino T; Watanabe K; Yoneyama H; Asakura H
Pathol Int; 2011 Apr; 61(4):228-38. PubMed ID: 21418395
[TBL] [Abstract][Full Text] [Related]
10. Anti-fibrogenic effect of PPAR-γ agonists in human intestinal myofibroblasts.
Koo JB; Nam MO; Jung Y; Yoo J; Kim DH; Kim G; Shin SJ; Lee KM; Hahm KB; Kim JW; Hong SP; Lee KJ; Yoo JH
BMC Gastroenterol; 2017 Jun; 17(1):73. PubMed ID: 28592228
[TBL] [Abstract][Full Text] [Related]
11. Increased lymphocyte apoptosis in mouse models of colitis upon ABT-737 treatment is dependent upon BIM expression.
Lutz C; Mozaffari M; Tosevski V; Caj M; Cippà P; McRae BL; Graff CL; Rogler G; Fried M; Hausmann M
Clin Exp Immunol; 2015 Aug; 181(2):343-56. PubMed ID: 25845418
[TBL] [Abstract][Full Text] [Related]
12. The Bcl-2 homology domain 3 mimetic ABT-737 targets the apoptotic machinery in acute lymphoblastic leukemia resulting in synergistic in vitro and in vivo interactions with established drugs.
High LM; Szymanska B; Wilczynska-Kalak U; Barber N; O'Brien R; Khaw SL; Vikstrom IB; Roberts AW; Lock RB
Mol Pharmacol; 2010 Mar; 77(3):483-94. PubMed ID: 20038611
[TBL] [Abstract][Full Text] [Related]
13. [Bcl-2 inhibitor ABT-737 enhances the cisplatin-induced apoptosis in breast cancer T47D cells].
Chen ZJ; Zhang B; Pan SH; Zhao HM; Zhang Y; Feng WH; Li YY; Cao XC
Zhonghua Zhong Liu Za Zhi; 2011 Dec; 33(12):891-5. PubMed ID: 22340096
[TBL] [Abstract][Full Text] [Related]
14. Mcl-1 down-regulation potentiates ABT-737 lethality by cooperatively inducing Bak activation and Bax translocation.
Chen S; Dai Y; Harada H; Dent P; Grant S
Cancer Res; 2007 Jan; 67(2):782-91. PubMed ID: 17234790
[TBL] [Abstract][Full Text] [Related]
15. B-cell lymphoma 2 inhibitor ABT-737 induces Beclin1- and reactive oxygen species-dependent autophagy in Adriamycin-resistant human hepatocellular carcinoma cells.
Yao X; Li X; Zhang D; Xie Y; Sun B; Li H; Sun L; Zhang X
Tumour Biol; 2017 Mar; 39(3):1010428317695965. PubMed ID: 28351336
[TBL] [Abstract][Full Text] [Related]
16. Caveolin-1 Alleviates Crohn's Disease-induced Intestinal Fibrosis by Inhibiting Fibroblasts Autophagy Through Modulating Sequestosome 1.
Yu M; Zhu W; Wang J; Chen X; He X; Lin B; Cen L; Zhou T; Lu C; Yu C; Sun J
Inflamm Bowel Dis; 2022 Jun; 28(6):923-935. PubMed ID: 35020883
[TBL] [Abstract][Full Text] [Related]
17. BH3 mimetics inhibit growth of chondrosarcoma--a novel targeted-therapy for candidate models.
Morii T; Ohtsuka K; Ohnishi H; Mochizuki K; Yoshiyama A; Aoyagi T; Hornicek FJ; Ichimura S
Anticancer Res; 2014 Nov; 34(11):6423-30. PubMed ID: 25368242
[TBL] [Abstract][Full Text] [Related]
18. The Oxysterol Synthesising Enzyme CH25H Contributes to the Development of Intestinal Fibrosis.
Raselli T; Wyss A; Gonzalez Alvarado MN; Weder B; Mamie C; Spalinger MR; Van Haaften WT; Dijkstra G; Sailer AW; Imenez Silva PH; Wagner CA; Tosevski V; Leibl S; Scharl M; Rogler G; Hausmann M; Misselwitz B
J Crohns Colitis; 2019 Sep; 13(9):1186-1200. PubMed ID: 31220227
[TBL] [Abstract][Full Text] [Related]
19. Influence of Bcl-2 family members on the cellular response of small-cell lung cancer cell lines to ABT-737.
Tahir SK; Yang X; Anderson MG; Morgan-Lappe SE; Sarthy AV; Chen J; Warner RB; Ng SC; Fesik SW; Elmore SW; Rosenberg SH; Tse C
Cancer Res; 2007 Feb; 67(3):1176-83. PubMed ID: 17283153
[TBL] [Abstract][Full Text] [Related]
20. New Therapeutic Approach for Intestinal Fibrosis Through Inhibition of pH-Sensing Receptor GPR4.
Weder B; Schefer F; van Haaften WT; Patsenker E; Stickel F; Mueller S; Hutter S; Schuler C; Baebler K; Wang Y; Mamie C; Dijkstra G; de Vallière C; Imenez Silva PH; Wagner CA; Frey-Wagner I; Ruiz PA; Seuwen K; Rogler G; Hausmann M
Inflamm Bowel Dis; 2022 Jan; 28(1):109-125. PubMed ID: 34320209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
